CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Orlistat

奥利司他 杂质对照品Orlistat Impurities

USP58 个杂质条目58 impurity entries

本页汇总 奥利司他 的 58 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 58 impurity reference standards of Orlistat with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 奥利司他(Orlistat)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical Methods[Related substances in orlistat detected with UPLC-MS/MS]
    Yao xue xue bao = Acta pharmaceutica Sinica · 2014 · Zhang TT, Ma C  ·  PMID 24961111
  2. 分析方法Analytical MethodsA stability-indicating high performance liquid chromatographic assay for the determination of orlistat in capsules
    Journal of chromatography. A · 2006 · Mohammadi A et al.  ·  PMID 16603170  ·  DOI
  3. 分析方法Analytical Methods[Simultaneous determination of rimonabant and orlistat illegally added in the weight-loss functional foods by high performance liquid chromatography-tandem mass spectrometry]
    Se pu = Chinese journal of chromatography · 2010 · Ma W et al.  ·  PMID 20458919  ·  DOI
  4. 分析方法Analytical MethodsThe Application of Quantitative ¹H-NMR for the Determination of Orlistat in Tablets
    Molecules (Basel, Switzerland) · 2017 · Sun S et al.  ·  PMID 28891958  ·  DOI
  5. 分析方法Analytical MethodsPharmacodynamic testing and new validated HPLC method to assess the interchangeability between multi-source orlistat capsules
    Drug design, development and therapy · 2017 · Zaid AN et al.  ·  PMID 29200824  ·  DOI

奥利司他 —— 原料药与杂质对照品Orlistat — drug substance & impurities

共 59 个条目(含原料药本体)59 items incl. the drug substance
Orlistat structure
USP原料药 APIAPI
奥利司他Orlistat
Orlistat
CAS No.96829-58-2
Chemical FormulaC29H53NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 1 (Orlistat USP Related Compound A) structure
USPA
奥利司他杂质1 (奥利司他USP相关化合物A)Orlistat Impurity 1 (Orlistat USP Related Compound A)
Orlistat Impurity 1 (Orlistat USP Related Compound A)
CAS No.104872-06-2
Chemical FormulaC22H42O3
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 2 (Orlistat USP Related Compound B) structure
USPB
奥利司他杂质2 (奥利司他USP相关化合物B)Orlistat Impurity 2 (Orlistat USP Related Compound B)
Orlistat Impurity 2 (Orlistat USP Related Compound B)
CAS No.19740-72-8
Chemical FormulaC8H16N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 3 (Orlistat USP Related Compound C) structure
USPC
奥利司他杂质3 (奥利司他USP相关化合物C)Orlistat Impurity 3 (Orlistat USP Related Compound C)
Orlistat Impurity 3 (Orlistat USP Related Compound C)
CAS No.791-28-6
Chemical FormulaC18H15OP
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 4 (Orlistat USP Related Compound D) structure
USPD
奥利司他杂质4 (奥利司他USP相关化合物D)Orlistat Impurity 4 (Orlistat USP Related Compound D)
Orlistat Impurity 4 (Orlistat USP Related Compound D)
CAS No.130793-27-0
Chemical FormulaC29H53NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 5 (Orlistat USP Related Compound E) structure
USPE
奥利司他杂质5 (奥利司他USP相关化合物E)Orlistat Impurity 5 (Orlistat USP Related Compound E)
Orlistat Impurity 5 (Orlistat USP Related Compound E)
CAS No.1072902-75-0
Chemical FormulaC29H53NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 6(Orlistat(S,R,R,R)-Isomer) structure
6
奥利司他杂质6(奥利司他(S,R,R,R)异构体)Orlistat Impurity 6(Orlistat(S,R,R,R)-Isomer)
Orlistat Impurity 6(Orlistat(S,R,R,R)-Isomer)
CAS No.111466-61-6
Chemical FormulaC29H53NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 7(Orlistat(S,S,R,R)-Isomer) structure
7
奥利司他杂质7(奥利司他(S,S,R,R)异构体)Orlistat Impurity 7(Orlistat(S,S,R,R)-Isomer)
Orlistat Impurity 7(Orlistat(S,S,R,R)-Isomer)
CAS No.111466-62-7
Chemical FormulaC29H53NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 8(Orlistat Dihydropyranone Impurity) structure
8
奥利司他杂质8(奥利司他二氢吡喃酮杂质)Orlistat Impurity 8(Orlistat Dihydropyranone Impurity)
Orlistat Impurity 8(Orlistat Dihydropyranone Impurity)
CAS No.130676-64-1
Chemical FormulaC22H40O2
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 9(Orlistat(S,S,R,S)-Isomer) structure
9
奥利司他杂质9(奥利司他(S,S,R,S)异构体)Orlistat Impurity 9(Orlistat(S,S,R,S)-Isomer)
Orlistat Impurity 9(Orlistat(S,S,R,S)-Isomer)
CAS No.130193-42-9
Chemical FormulaC29H53NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 10(Orlistat(S,S,S,R)-Isomer) structure
10
奥利司他杂质10(奥利司他(S,S,S,R)异构体)Orlistat Impurity 10(Orlistat(S,S,S,R)-Isomer)
Orlistat Impurity 10(Orlistat(S,S,S,R)-Isomer)
CAS No.130193-40-7
Chemical FormulaC29H53NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 11 structure
11
奥利司他杂质11Orlistat Impurity 11
Orlistat Impurity 11
CAS No.2446-83-5
Chemical FormulaC8H14N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 12 (Orlistat(R,R,R,R)-Isome) structure
12
奥利司他杂质12 (奥利司他(R,R,R,R)异构体)Orlistat Impurity 12 (Orlistat(R,R,R,R)-Isome)
Orlistat Impurity 12 (Orlistat(R,R,R,R)-Isome)
CAS No.104872-27-7
Chemical FormulaC29H53NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 15(Orlistat(S,R,S,S)-Isomer) structure
15
奥利司他杂质15 (奥利司他(S,R,S,S)异构体)Orlistat Impurity 15(Orlistat(S,R,S,S)-Isomer)
Orlistat Impurity 15(Orlistat(S,R,S,S)-Isomer)
CAS No.111466-63-8
Chemical FormulaC29H53NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 16(Orlistat(R,S,R,R)-Isomer) structure
16
奥利司他杂质16 (奥利司他(R,S,R,R)异构体)Orlistat Impurity 16(Orlistat(R,S,R,R)-Isomer)
Orlistat Impurity 16(Orlistat(R,S,R,R)-Isomer)
CAS No.1620409-08-6
Chemical FormulaC29H53NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 17 ((R,S,S,S)-Orlistat) structure
17
奥利司他杂质17 ((R,S,S,S)-奥利司他)Orlistat Impurity 17 ((R,S,S,S)-Orlistat)
Orlistat Impurity 17 ((R,S,S,S)-Orlistat)
CAS No.104872-28-8
Chemical FormulaC29H53NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 18(Orlistat(R,R,S,S)-Isomer) structure
18
奥利司他杂质18 (奥利司他(R,R,S,S)异构体)Orlistat Impurity 18(Orlistat(R,R,S,S)-Isomer)
Orlistat Impurity 18(Orlistat(R,R,S,S)-Isomer)
CAS No.1225451-00-2
Chemical FormulaC29H53NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 19 (Orlistat(S,R,S,R)-Isomer) structure
19
奥利司他杂质19 (奥利司他(S,R,S,R)异构体)Orlistat Impurity 19 (Orlistat(S,R,S,R)-Isomer)
Orlistat Impurity 19 (Orlistat(S,R,S,R)-Isomer)
CAS No.130193-41-8
Chemical FormulaC29H53NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 22(Orlistat(S,R,R,S)-Isomer) structure
22
奥利司他杂质22(奥利司他(S,R,R,S)异构体Orlistat Impurity 22(Orlistat(S,R,R,S)-Isomer)
Orlistat Impurity 22(Orlistat(S,R,R,S)-Isomer)
CAS No.130193-43-0
Chemical FormulaC29H53NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 23 (Orlistat Tetradehydro Impurity) (Lipstatin) structure
23
奥利司他杂质23 (奥利司他四脱氢杂质) (利普司他汀)Orlistat Impurity 23 (Orlistat Tetradehydro Impurity) (Lipstatin)
Orlistat Impurity 23 (Orlistat Tetradehydro Impurity) (Lipstatin)
CAS No.96829-59-3
Chemical FormulaC29H49NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 24 (N-Formyl-L-leucine) structure
24
奥利司他杂质24 (N-甲酰基-L-亮氨酸)Orlistat Impurity 24 (N-Formyl-L-leucine)
Orlistat Impurity 24 (N-Formyl-L-leucine)
CAS No.6113-61-7
Chemical FormulaC7H13NO3
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 25 structure
25
奥利司他杂质25Orlistat Impurity 25
Orlistat Impurity 25
CAS No.68711-40-0
Chemical FormulaC22H42O3
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 26 structure
26
奥利司他杂质26Orlistat Impurity 26
Orlistat Impurity 26
CAS No.130793-28-1
Chemical FormulaC29H55NO6
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 27 structure
27
奥利司他杂质27Orlistat Impurity 27
Orlistat Impurity 27
CAS No.130676-66-3
Chemical FormulaC29H55NO6
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 28 structure
28
奥利司他杂质28Orlistat Impurity 28
Orlistat Impurity 28
CAS No.130676-63-0
Chemical FormulaC28H53NO3
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 29 structure
29
奥利司他杂质29Orlistat Impurity 29
Orlistat Impurity 29
CAS No.3084279-49-9
Chemical FormulaC37H64N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 30 structure
30
奥利司他杂质30Orlistat Impurity 30
Orlistat Impurity 30
CAS No.1356019-68-5
Chemical FormulaC30H55NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 31 structure
31
奥利司他杂质31Orlistat Impurity 31
Orlistat Impurity 31
CAS No.68711-33-1
Chemical FormulaC22H42O3
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 32 structure
32
奥利司他杂质32Orlistat Impurity 32
Orlistat Impurity 32
CAS No.130793-26-9
Chemical FormulaC22H42O3
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 36 structure
36
奥利司他杂质36Orlistat Impurity 36
Orlistat Impurity 36
CAS No.1243011-56-4
Chemical FormulaC31H57NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 40 structure
40
奥利司他杂质40Orlistat Impurity 40
Orlistat Impurity 40
CAS No.1204938-98-6
Chemical FormulaC29H49NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 41 structure
41
奥利司他杂质41Orlistat Impurity 41
Orlistat Impurity 41
CAS No.1204938-96-4
Chemical FormulaC29H53NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 42 structure
42
奥利司他杂质42Orlistat Impurity 42
Orlistat Impurity 42
CAS No.130676-65-2
Chemical FormulaC29H53NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 43 structure
43
奥利司他杂质43Orlistat Impurity 43
Orlistat Impurity 43
CAS No.155548-91-7
Chemical FormulaC22H42O3
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 44 structure
44
奥利司他杂质44Orlistat Impurity 44
Orlistat Impurity 44
CAS No.160549-09-7
Chemical FormulaC22H42O3
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 63 structure
63
奥利司他杂质63Orlistat Impurity 63
Orlistat Impurity 63
CAS No.1356841-82-1
Chemical FormulaC30H55NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 65 structure
65
奥利司他杂质65Orlistat Impurity 65
Orlistat Impurity 65
CAS No.1119226-56-0
Chemical FormulaC30H55NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 69 structure
69
奥利司他杂质69Orlistat Impurity 69
Orlistat Impurity 69
CAS No.1243107-50-7
Chemical FormulaC28H51NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 70 structure
70
奥利司他杂质70Orlistat Impurity 70
Orlistat Impurity 70
CAS No.104801-94-7
Chemical FormulaC22H42O3
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 74 structure
74
奥利司他杂质74Orlistat Impurity 74
Orlistat Impurity 74
CAS No.686744-60-5
Chemical FormulaC31H57NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 80 structure
80
奥利司他杂质80Orlistat Impurity 80
Orlistat Impurity 80
CAS No.1356847-30-7
Chemical FormulaC30H55NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 81 structure
81
奥利司他杂质81Orlistat Impurity 81
Orlistat Impurity 81
CAS No.881900-54-5
Chemical FormulaC57H106N2O9
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 82 structure
82
奥利司他杂质82Orlistat Impurity 82
Orlistat Impurity 82
CAS No.1356354-38-5
Chemical FormulaC28H51NO5S
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 83 structure
83
奥利司他杂质83Orlistat Impurity 83
Orlistat Impurity 83
CAS No.1356354-21-6
Chemical FormulaC28H51NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 84 structure
84
奥利司他杂质84Orlistat Impurity 84
Orlistat Impurity 84
CAS No.1356017-35-0
Chemical FormulaC33H61NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 85 structure
85
奥利司他杂质85Orlistat Impurity 85
Orlistat Impurity 85
CAS No.108051-94-1
Chemical FormulaC36H59NO6
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 86 structure
86
奥利司他杂质86Orlistat Impurity 86
Orlistat Impurity 86
CAS No.1356019-45-8
Chemical FormulaC31H57NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 89 structure
89
奥利司他杂质89Orlistat Impurity 89
Orlistat Impurity 89
CAS No.136890-12-5
Chemical FormulaC22H42O3
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 98 structure
98
奥利司他杂质98Orlistat Impurity 98
Orlistat Impurity 98
CAS No.89810-44-6
Chemical FormulaC7H13NO3
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 99 structure
99
奥利司他杂质99Orlistat Impurity 99
Orlistat Impurity 99
CAS No.93923-85-4
Chemical FormulaC5H8N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 100 structure
100
奥利司他杂质100Orlistat Impurity 100
Orlistat Impurity 100
CAS No.93893-56-2
Chemical FormulaC5H9NO4
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 101 structure
101
奥利司他杂质101Orlistat Impurity 101
Orlistat Impurity 101
CAS No.1681-96-5
Chemical FormulaC6H9NO5
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 104 structure
104
奥利司他杂质104Orlistat Impurity 104
Orlistat Impurity 104
CAS No.1404825-23-5
Chemical FormulaC8H15NO3
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 105 structure
105
奥利司他杂质105Orlistat Impurity 105
Orlistat Impurity 105
CAS No.104872-03-9
Chemical FormulaC22H42O3
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 106 structure
106
奥利司他杂质106Orlistat Impurity 106
Orlistat Impurity 106
CAS No.137306-81-1
Chemical FormulaC21H44O3Si
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 107 structure
107
奥利司他杂质107Orlistat Impurity 107
Orlistat Impurity 107
CAS No.155211-59-9
Chemical FormulaC20H44O2Si
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 108 structure
108
奥利司他杂质108Orlistat Impurity 108
Orlistat Impurity 108
CAS No.137306-82-2
Chemical FormulaC20H42O2Si
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 109 structure
109
奥利司他杂质109Orlistat Impurity 109
Orlistat Impurity 109
CAS No.89397-99-9
Chemical FormulaC13H19NOS
Purity>95%询价On request
10mg25mg50mg100mg
Orlistat Impurity 110 structure
110
奥利司他杂质110Orlistat Impurity 110
Orlistat Impurity 110
CAS No.173067-58-8
Chemical FormulaC19H33NOSSi
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

奥利司他 —— 研究文献与合成路线Orlistat — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 奥利司他 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Orlistat. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Comparison of impurity profiles of Orlistat pharmaceutical products using HPLC tandem mass spectrometry
    Schneider A, Wessjohann LA · Journal of pharmaceutical and biomedical analysis · 2010 · 被引 6cited 6
  2. A stability-indicating high performance liquid chromatographic assay for the determination of orlistat in capsules
    Mohammadi A, Haririan I, Rezanour N, et al. · Journal of chromatography. A · 2006 · 被引 8cited 8

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR THE PREPARATION OF ORLISTAT
    BAPUSO PATIL DATTATRAY, PATEL KILLOL, PRASAD ASHOK, DEO KESHAV, et al. · 公开号 KR20100027133KR20100027133 · 2010
  2. PROCESS FOR THE PREPARATION OF ORLISTAT
    BAPUSO PATIL DATTATRAY, PATEL KILLOL, PRASAD ASHOK, DEO KESHAV, et al. · 公开号 US2010179335US2010179335 · 2010
  3. PROCESS FOR THE PREPARATION OF ORLISTAT
    BAPUSO PATIL DATTATRAY, PATEL KILLOL, PRASAD ASHOK, DEO KESHAV, et al. · 公开号 EP2164839EP2164839 · 2010
  4. ORLISTAT CRYSTALLINE FORM AND PROCESS FOR PREPARING THE SAME
    LEE SEONG GUK, CHOI DONG OK, JANG DO YOUNG, JEON SEONG HYEON, et al. · 公开号 KR20100122592KR20100122592 · 2010
  5. PROCESS FOR THE PREPARATION OF AN ORLISTAT DERIVATIVE USEFUL AS REFERENCE STANDARD IN THE DETERMINATION OF THE PURITY OF ORLISTAT AND PROCESS FOR THE PREPARATION OF ORLISTAT
    KANWAR SEEMA, PATEL KILLOL, NAYYAR KAUSHAL, DEO KESHAV, et al. · 公开号 WO2006035296WO2006035296 · 2006

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

奥利司他 杂质谱研究要点Orlistat — impurity profiling notes

下面这些是拿到 奥利司他 的 59 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 59 impurity entries for Orlistat, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances